ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,561,000 | -5.3% | 237,155 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,704,000 | +25.2% | 237,155 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $2,160,000 | -38.9% | 237,155 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $3,538,000 | -42.0% | 237,155 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $6,095,000 | -1.5% | 237,155 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $6,185,000 | -26.2% | 237,155 | -0.1% | 0.01% | -33.3% |
| Q1 2021 | $8,379,000 | -30.0% | 237,353 | -50.0% | 0.01% | +33.3% |
| Q4 2020 | $11,972,000 | +33.9% | 474,310 | +100.0% | 0.01% | -43.8% |
| Q3 2020 | $8,943,000 | -11.9% | 237,155 | 0.0% | 0.02% | -23.8% |
| Q2 2020 | $10,155,000 | +120.3% | 237,155 | 0.0% | 0.02% | +90.9% |
| Q1 2020 | $4,610,000 | – | 237,155 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $45,386,000 | 9.32% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $472,400,000 | 5.23% |
| Wildcat Capital Management, LLC | 1,515,524 | $38,252,000 | 4.81% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 900,143 | $22,720,000 | 3.28% |
| Coastal Bridge Advisors, LLC | 385,824 | $9,738,000 | 1.93% |
| Casdin Capital, LLC | 945,000 | $23,852,000 | 0.71% |
| DSAM Partners (London) Ltd | 208,798 | $5,270,000 | 0.62% |
| BAINCO INTERNATIONAL INVESTORS | 152,839 | $3,858,000 | 0.44% |
| Pier Capital, LLC | 152,071 | $3,838,000 | 0.41% |
| Woodline Partners LP | 567,539 | $14,325,000 | 0.38% |